MicroRNA Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2030

  • Single User License $3500

MicroRNA Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2030

Status : May, 2021 | Biotechnology

Report Digest


MicroRNA Market: Overview

The global microRNA market is predicted to expand at a whopping growth rate over the 2020 – 2030 forecast period. This is mainly attributed to emergence of microRNA tools for disease-related analytical applications, immense traction earned by miRNA targeted prediction and identification, continued wide adoption of majority of miRNA tools. In addition, miRNA are among the most important potential biopharmaceutical prospects that are penetrating the commercial space for developing potential future medicines.

Key attributes based on which the microRNA market is divided in this report are product, service, end-use, application, and region.

The report entails demand dynamics and growth indices for an all-inclusive analysis of the microRNA market for the 2020 – 2030 forecast period. Furthermore, analysis of key segments and insights into the competitive landscape of the microRNA market are important elements of the research report.

MicroRNA Market: Competitive Landscape

The microRNA market is intensely competitive with several large biopharmaceutical companies that have strong presence. Expansion of patent portfolio is a key growth strategy that keen players in the microRNA market are engaged in. For example, in July 2020, Sistemic Ltd announced the expansion of patent covering for the use of microRNAs for predictive analysis of cellular function. Under the patent, the microRNA expression study of mesenchymal stem cells acquired from different donors to identify miRNAs that will subsequently be linked to cellular functions to support donor screening and develop MSCs based cell therapies are covered.

Prominent players operating in the microRNA market include;

  • Merck KGaA
  • Horizon Discovery Ltd
  • QiAGEN
  • New England Biolabs
  • NanoString
  • SeqMatic LLC
  • Sistemic Scotland Limited
  • OriGene Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • Synlogic
  • GeneCopoeia Inc.
  • Quantabio
  • BioGenex
  • Miltenyi
  • Biotec
  • Biodynamics Laboratory Inc.

MicroRNA Market: Key Trends

Firstly, increasing efforts of biopharmaceutical companies for the discovery of new therapeutic molecules that can work as new drugs is spelling growth in the microRNA market. There are a number of miRNA-based prospects that are under clinical testing such as anti-miR compounds and certain inhibitors for miRNAs which can work as potential therapeutic solutions. For such reasons, RNA therapeutics is witnessing attractive investments for the development of profitable drugs.

Moreover, increasing adoption of microRNA as a biomarker for diagnosis of diseases is creating opportunities in the microRNA market. For example, miRNA biomarkers gather particular attention for genome-wide studies for data-driven methodology as they are characteristic of high reproducibility and strength when compared to conventional methods. Hence, miRNA serves as promising candidates for the development of biomarkers.

Besides this, the rising interest in liquid biopsies for the diagnosis of rare cancers has led to the increasing importance of miRNAs for the discovery and development of a gamut of biomarkers.

MicroRNA Market: Regional Landscape

North America led the overall microRNA market accounting the leading revenue share among other key regions in the recent past. Factors such as presence of key players, extensive R&D, and established research infrastructure for genomics, proteomics, and oncology account for lead position of North America in the microRNA market. In addition, FDA patent approvals received by companies for their miRNA biomarkers consolidates the position of North America in the microRNA market. For example, in May 2020, DiamiR received US patent approval for miRNA-based techniques for detecting and monitoring brain aging. Under the patent, methods for the quantitative analysis of miRNA present in identifiable blood plasma and brain as the biomarkers for brain aging are covered.

Asia Pacific is expected to witness the leading growth rate in the microRNA market in the coming years. This growth can be attributed to rapid progress in genomic studies and the adoption of new tools to support research initiatives.

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?